Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor &Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ROTEM - rotation thromboelastometry testing | Device | The ROTEM® is a simple blood test that provides information about specific components involved in blood clotting and stopping hemorrhage. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluating degrees of Fibrin polymerization (FIBTEM) ROTEM in the immediate postpartum period. | After delivery through study completion, an average of 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluating INTEM, EXTEM and APTEM Clotting time in pre and post-delivery. | Pre and post-delivery through study completion, an average of 2 years | |
| Evaluating volume of estimated and quantitative blood loss | Pre and post-delivery through study completion, an average of 2 years |
Not provided
Inclusion Criteria:
Age ≥ 18 years and able to provide consent
Gestational age ≥ 34 weeks
≥ 1 High-risk of postpartum hemorrhage criteria defined as either of:
Exclusion Criteria:
Not provided
Not provided
Pregnant women with high risk of postpartum hemorrhage
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine | Columbus | Ohio | 43210 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Evaluating change in hemoglobin/hematocrit ratio between values on admission for delivery (or in the last 4 weeks prior to delivery) and at 24 (+/-4) hours postpartum | Pre and post-delivery through study completion, an average of 2 years |
| Evaluating amount of Postpartum hemorrhage defined as Quantitative Blood Loss >500ml for vaginal delivery and >1000ml for cesarean delivery | Pre and post-delivery through study completion, an average of 2 years |
| Evaluating frequency of blood transfusion and related morbidities | Pre and post-delivery through study completion, an average of 2 years |
| Evaluating number of severe maternal morbidity (including admission to ICU, intubation, shock) | Pre and post-delivery through study completion, an average of 2 years |
| Evaluating incidence of need for surgical and non-surgical interventions to manage Postpartum hemorrhage (PPH) | Pre and post-delivery through study completion, an average of 2 years |